Take a Look at the Top-Performing Biotech ETFs YTD – Investing.com

Take a Look at the Top-Performing Biotech ETFs YTD – Investing.com

The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq Biotechnology Index rising about 6.9% so far in 2021.

The coronavirus pandemic has been a rising concern as its variants, particularly Delta, have aggravated the spread. However, the launch of certain COVID-19 vaccines from Moderna (NASDAQ:) MRNA, Pfizer Inc. (NYSE:) PFE and BioNTech SE (NASDAQ:) BNTX, and Johnson & Johnson JNJ has been helping control the outbreak.

It is worth noting here that the FDA had earlier granted the first full U.S. approval to Pfizer/BioNTech’s coronavirus vaccine. According to the FDA, the approval has been provided after evaluating enormous vaccine data covering about 40,000 trial participants and reflecting 91% efficiency in preventing COVID-19 (per a CNBC article).